Glassman Wealth Services »

Denali Therapeutics shares owned by Glassman Wealth Services

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Glassman Wealth Services from 13F filings

Historical chart of Glassman Wealth Services investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Glassman Wealth Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Glassman Wealth Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $622 29 21.45
2023-09-30 $948 46 20.63

More positions owned by Glassman Wealth Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Glassman Wealth Services

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
Geode Capital Management
Marshall Wace
Bank of New York Mellon
T. Rowe Price Associates
Credit Suisse
Citadel Advisors
Flagship Ventures Management
Federated Investors
Dimensional Fund Advisors

View all funds holding Denali Therapeutics